Medical Xpress February 10, 2025
Gordy Slack, Stanford University

Sepsis, a life-threatening organ dysfunction, is responsible for an estimated 1 in 5 deaths globally and 1 in 3 deaths that occur within a U.S. hospital. It happens due to a dysregulated immune response to infection, and its high mortality rate correlates to the difficulty in quickly diagnosing and appropriately addressing the origin of infection, be it bacterial, viral, or some other pathogen. Current methods can delay that life-or-death determination for as long as three days.

Enter the Stanford Medicine lab of Purvesh Khatri, where a test developed to reduce that time frame to roughly 30 minutes—an advancement that could be transformative for millions of patients each year—was cleared by the Food and Drug Administration in January.

Khatri, Ph.D., a...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Health System / Hospital, Provider
Novartis Nabs First FDA Nod in Rare Kidney Disease, But Apellis Pharma Is on Its Heels
Scientist Whose Work Led FDA to Ban Food Dye Says Agency Overstated Risk
Who’s Leading the FDA’s AI Race? Top Medical Specialties and Companies to Watch
FDA Funding Changes Could Impact Biotech M&A
FDA issues flu vaccine recommendations: 5 respiratory updates

Share This Article